Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk

Keyphrases

• Immune Microenvironment 100%
• Immune Profiling 100%
• Multiplexing 100%
• Invasive Breast Cancer 100%
• Breast Cancer Risk 100%
• Ductal Carcinoma in Situ 100%
• CD8+ T Cells 20%
• Ki-67 20%
• Immune Parameters 20%
• In Situ Cell 20%
• CD3+ 20%
• Multiplex Immunofluorescence 20%
• Follow-up Time 10%
• T Cells 10%
• B Cells 10%
• Regulatory T Cells 10%
• Dutch Population 10%
• Overtreatment 10%
• Human Epidermal Growth Factor Receptor 2 (HER2) 10%
• Population-based Cohort 10%
• CD8+ 10%
• Breast Cancer Cases 10%
• HER2 Status 10%
• FoxP3+ 10%
• CD20+ 10%
• Perivascular Fibrosis 10%
• Invasive Recurrence 10%
• CD3+CD8+ 10%
• CD68+ 10%
• Comedonecrosis 10%
• Whole Slide Analysis 10%

Immunology and Microbiology

• Immunity 100%
• CD3 Antigen 75%
• Immunocompetent Cell 50%
• Cytotoxic T-Cell 50%
• Immunofluorescence 50%
• B Cell 25%
• T Cell 25%
• Regulatory T Cell 25%
• CD68 25%
• CD20 25%
• CD8 25%
• FOXP3 25%

Biochemistry, Genetics and Molecular Biology

• Immunity 100%
• T Cell 75%
• CD8 75%
• Immunocompetent Cell 50%
• Immunofluorescence 50%
• B Cell 25%
• Regulatory T Cell 25%
• CD20 25%
• CD68 25%
• FOXP3 25%